Novus Biologicals™ Recombinant Human PARP Protein

Catalog No.	Quantity
NB002055	50 μg

Catalog No. NB002055 Supplier Novus Biologicals™ Supplier No. NBP19963550UG

Description

Highly purified and high bioactivity. Generating reliable and reproducible results.

Recombinant bioactive protein for Human PARP The Recombinant Human PARP Protein is derived from Baculovirus. The Recombinant Human PARP Protein has been validated for the following applications: SDS-Page, Bioactivity.

Specifications

• Concentration: Lyoph
• For Use With (Application): Bioactivity, SDS-PAGE
• Formulation: Lyophilized.
• Gene ID (Entrez): 142
• Molecular Weight (g/mol): 116 kDa
• Quantity: 50 μg
• Source: Baculovirus
• Storage Requirements: Store at -20 to -80C. Avoid freeze-thaw cycles.
• Gene Alias: ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase), ADPRT 1, ADPRTADP-ribosyltransferase NAD(+), EC 2.4.2, EC 2.4.2.30, NAD(+) ADP-ribosyltransferase 1, PARP apoptosis, PARP-1, PARPADPRT1, poly (ADP-ribose) polymerase 1, poly (ADP-ribose) polymerase family, member 1, poly [ADP-ribose] polymerase 1, poly(ADP-ribose) polymerase, poly(ADP-ribose) synthetase, poly(ADP-ribosyl)transferase, Poly[ADP-ribose] synthase 1, PPOLpADPRT-1
• Gene Symbol: PARP1
• Reconstitution: Centrifuge the vial prior to opening. Add 100 μL dH2O for a concentration of 0.5 mg/mL. Final buffer concentration: 20 mM Tris (pH 8), 0.3 M NaCl, 0.1 mM EDTA, 1 mM DTT, plus lyophilization stabilizers.
• Buffer: Lyophilized.
• Purity or Quality Grade: >95%, by SDS-PAGE